• Our Mission
    • Overview
    • Leadership
  • Science & Technology
    • CoreX™
    • AlloChem™
    • Mine™
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • SEDAR+ Filings
    • Stock Information
    • Leadership
    • Investor FAQ
    • Email Alerts

Sharp Therapeutics Corp. Announces Fourth Quarter 2025 Results, Closing of Convertible Note Offering and Adoption of Semi-Annual Reporting

Apr 17, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 17, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) announces the release of its annual audited...

Sharp Therapeutics Updates on ‘901 for Gaucher and GBA1 Parkinson’s and Platform Programs

Apr 10, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 10, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) announces that following longer-term non-GLP testing the company...

Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering

Apr 10, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 10, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the fourth tranche...

Sharp Therapeutics Announces Closing of Third Tranche of Unsecured Convertible Note Offering

Apr 2, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – April 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the third tranche (the...

Sharp Therapeutics Announces Closing of Second Tranche of Unsecured Convertible Note Offering

Mar 13, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – March 13, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the second tranche...

Sharp Therapeutics Announces Closing of First Tranche of Unsecured Convertible Note Offering

Feb 27, 2026 | Press Releases

Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 27, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company”) is pleased to announce that it has closed the first tranche...
« Older Entries
Next Entries »

Recent Posts

  • Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
  • Sharp Therapeutics Announces Closing of Non-Brokered Private Placement
  • Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
  • Sharp Therapeutics Announces Non-Brokered Private Placement and Provides Operational Update
  • Sharp Therapeutics Announces Filing of Amended and Restated Management Information Circular and New Annual Meeting Date

Recent Comments

No comments to show.

Stay connected

  • Our Mission
    • Overview
    • Leadership
  • Science & Technology
    • CoreX™
    • AlloChem™
    • Mine™
  • Pipeline
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • SEDAR+ Filings
    • Stock Information
    • Leadership
    • Investor FAQ
    • Email Alerts
  • Follow
  • Follow
  • Follow

© Sharp Therapeutics Corp. All Rights Reserved.